The DOI matches its Crossref record; 770 of the 770 references it cites were found in a registry or an index.
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
Open accessAbstract
Virus-like particle (VLP) technology is a promising approach for the construction of novel vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived from non-enveloped icosahedral or helical viruses and proved to be viable vaccine candidates due to their effective presentation of epitopes in a native conformation. VLP technology has also been used to prepare chimeric VLPs decorated with genetically fused or chemically coupled epitope stretches selected from immunologically defined target proteins. However, structural constraints associated with the rigid geometrical architecture of icosahedral or helical VLPs pose challenges for the expression and presentation of large epitopes. Complex VLPs derived from non-symmetric enveloped viruses are increasingly being used to incorporate large epitopes and even full-length foreign proteins. Pleomorphic VLPs derived from influenza or other enveloped viruses can accommodate multiple full-length and/or chimeric proteins that can be rationally designed for multifunctional purposes, including multivalent vaccines. Therefore, a second generation of VLP carriers is represented by complex particles reconstructed from natural or chimeric structural proteins derived from complex enveloped viruses. Further development of safe and efficient VLP nanotechnology may require a rational combination of both approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 601–770 of 770
High-throughput in vivo screening of targeted molecular imaging agents
Gagnon, M.-H., Hausner, S. H., Mařı́k, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906925106 · Cited by 71
Nikles, D., Bach, P., Böller, K., Merten, C. A., Montrasio, F., Heppner, F. L., Aguzzi, A., Cichutek, K., Kalinke, U., & Buchholz, C. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4033-4042.2005 · Cited by 71
Dkhissi, F., Lu, H., Soria, C., Opolon, P., Griscelli, F., Liu, H., Khattar, P., Mishal, Z., Perricaudet, M., & Li, H. (2003) · Human Gene Therapy · doi:10.1089/104303403766682250 · Cited by 71
RNA motifs that determine specificity between a viral replicase and its promoter.
Tinoco, I., Kim, C., & Kao, C. C. (2000) · Nature Structural Biology · doi:10.1038/75202 · Cited by 70
Demberg, T., & Robert-Guroff, M. (2009) · International Reviews of Immunology · doi:10.1080/08830180802684331 · Cited by 69
Londoño, P., Chatfield, S. N., Tindle, R. W., Herd, K., Gao, X., Frazer, I. H., & Gordon Dougan, B. (1996) · Vaccine · doi:10.1016/0264-410x(95)00216-n · Cited by 69
Viral Protein Determinants of Lassa Virus Entry and Release from Polarized Epithelial Cells
Schlie, K., Maisa, A., Freiberg, F., Groseth, A., Strecker, T., & Garten, W. (2010) · Journal of Virology · doi:10.1128/jvi.02240-09 · Cited by 69
Cooper, C., & Mackie, D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.162 · Cited by 69
Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesions
Kanodia, S., Silva, D. M. D., & Kast, W. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.23252 · Cited by 68
Michel, M. L., Bourgine, M., Sobczak, E., Favier, V., Guétard, D., Bahraoui, E., & Tiollais, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7957 · Cited by 68
Fraillery, D., Baud, D., Pang, S., Schiller, J. T., Bobst, M., Zosso, N., Ponci, F., & Nardelli‐Haefliger, D. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00164-07 · Cited by 68
Huet, D., Bagot, M., Loyaux, D., Capdevielle, J., Conraux, L., Ferrara, P., Bensussan, A., & Marie‐Cardine, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.652 · Cited by 67
Chou, Y.-H., Opal, P., Quinlan, R. A., et al. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.4.817 · Cited by 67
González, M. J., Plummer, E. M., Rae, C. S., & Manchester, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007981 · Cited by 66
Long‐lasting cross‐presentation of tumor antigen in human DC
Faure, F., Mantegazza, A. R., Sadaka, C., Sedlik, C., Jotereau, F., & Amigorena, S. (2009) · European Journal of Immunology · doi:10.1002/eji.200838669 · Cited by 66
Advances in Virus-Like Particle Vaccines for Filoviruses
Warfield, K. L., & Aman, M. J. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir346 · Cited by 66
Reddy, D. V. R., Sudarshana, M. R., Fuchs, M., Rao, N. C., & Thottappilly, G. (2009) · Advances in virus research · doi:10.1016/s0065-3527(09)07506-x · Cited by 65
Bucarey, S. A., Noriega, J., Reyes, P., Tapia, C. V., Sáenz, L., Zúñiga, A., & Tobar, J. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.061 · Cited by 65
Rosevear, E. R., McReynolds, M., & Goldman, R. D. (1990) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970170303 · Cited by 65
Guerra‐Peraza, O., Kirk, D., Seltzer, V., Veluthambi, K., Schmit, A., Höhn, T., & Herzog, E. (2005) · Journal of General Virology · doi:10.1099/vir.0.80920-0 · Cited by 65
High-density Functional Display of Proteins on Bacteriophage Lambda
Gupta, A., Onda, M., Pastan, I. H., Adhya, S. L., & Chaudhary, V. K. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.033 · Cited by 65
Suci, P. A., Berglund, D. L., Liepold, L. O., Brumfield, S. K., Pitts, B., Davison, W., Oltrogge, L. M., Hoyt, K. O., Codd, S. L., Stewart, P. S., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.02.006 · Cited by 64
The cell biology of HIV-1 and other retroviruses
Freed, E. O., & Mouland, A. J. (2006) · Retrovirology · doi:10.1186/1742-4690-3-77 · Cited by 64
Packaging of Brome Mosaic Virus RNA3 Is Mediated through a Bipartite Signal
Choi, Y. G., & Rao, A. L. N. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9750-9757.2003 · Cited by 64
Virus-Like Particles as a Vaccine Delivery System: Myths and Facts
Roy, P., & Noad, R. J. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1132-2_11 · Cited by 64
Johnson, P. R., Montefiori, D. C., Goldstein, S., et al. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2175 · Cited by 63
Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches
Campo, M. S., & Roden, R. B. S. (2009) · Journal of Virology · doi:10.1128/jvi.01927-09 · Cited by 63
Björling, E., Broliden, K., Bernardi, D., Utter, G., Thorstensson, R., Chiodi, F., & Norrby, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6082 · Cited by 62
Matassov, D., Cupo, A., & Galarza, J. M. (2007) · Viral Immunology · doi:10.1089/vim.2007.0027 · Cited by 62
Nassal, M. (1988) · Gene · doi:10.1016/0378-1119(88)90364-2 · Cited by 62
Role of the N-terminal part of the coat protein in the assembly of cowpea chlorotic mottle virus
Vriend, G., Verduin, B. J. M., & Hemminga, M. A. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90140-3 · Cited by 60
Martin, S. J., Vyakarnam, A., CHEINGSONG-POPOV, R., Callow, D., Jones, K. L., Senior, J. M., Adams, S. E., Kingsman, A. J., Matear, P. M., & Gotch, F. (1993) · PubMed · Cited by 60
Bai, B., Hu, Q., Hu, H., Zhou, P., Shi, Z., Meng, J., Lu, B., Huang, Y., Mao, P., & Wang, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002685 · Cited by 59
Pejawar‐Gaddy, S., Rajawat, Y. S., Hilioti, Z., Jia, X., Gaddy, D. F., Finn, O. J., Viscidi, R. P., & Bossis, I. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0895-0 · Cited by 59
Spohn, G., Schwarz, K., Maurer, P., Illges, H., Rajasekaran, N., Choi, Y., Jennings, G. T., & Bachmann, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6211 · Cited by 58
Griffiths, J., Berrie, E., Holdsworth, L. N., Moore, J. P., Harris, S. J., Senior, J. M., Kingsman, S. M., Kingsman, A. J., & Adams, S. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.450-456.1991 · Cited by 58
Lucas, R. W., Kuznetsov, Y. G., Larson, S. B., & McPherson, A. (2001) · Virology · doi:10.1006/viro.2000.0897 · Cited by 58
Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops
Slupetzky, K., Shafti‐Keramat, S., Lenz, P., et al. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-11-2799 · Cited by 58
Honeychurch, K. M., Yang, G., Jordan, R., & Hruby, D. E. (2007) · Journal of Virology · doi:10.1128/jvi.00034-07 · Cited by 58
Zamora, E. D., Handisurya, A., Shafti‐Keramat, S., Borchelt, D., Rudow, G. L., Conant, K. E., Cox, C., Troncoso, J. C., & Kirnbauer, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2662 · Cited by 56
McBurney, S. P., Young, K. R., & Ross, T. M. (2006) · Virology · doi:10.1016/j.virol.2006.08.032 · Cited by 56
Luo, L., Li, Y., & Kang, C. Y. (1990) · Virology · doi:10.1016/0042-6822(90)90159-o · Cited by 56
von Euw, E. M., Barrio, M. M., Furman, D., Bianchini, M., Levy, E. M., Yee, C., Li, Y., Wainstok, R., & Mordoh, J. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-19 · Cited by 56
González, A., NGUYEN, T. V., Azevedo, M. S. P., JEONG, K., AGARIB, F., Iosef, C., CHANG, K., Lövgren-Bengtsson, K., Morein, B., & Saif, L. J. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02395.x · Cited by 55
Zhu, Z. H., Chen, S. S., & Huang, A. (1990) · PubMed · Cited by 55
Role of lipid rafts in virus assembly and budding
Nayak, D. P., & Barman, S. (2002) · Advances in virus research · doi:10.1016/s0065-3527(02)58001-5 · Cited by 54
The Role of Lipid Microdomains in Virus Biology
Nayak, D. P., & Hui, E. K. (2004) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4757-5806-1_14 · Cited by 53
Aptamer-Modified Nanodrug Delivery Systems
Wu, Z., Tang, L., Zhang, X., Jiang, J., & Tan, W. (2011) · ACS Nano · doi:10.1021/nn2037384 · Cited by 53
Eaton, B. T., Gould, A. R., Hyatt, A. D., Coupar, B. E. H., Martyn, J. C., & White, J. R. (1991) · Virology · doi:10.1016/0042-6822(91)90082-m · Cited by 53
Nieland, J. D., Silva, D. M. D., Velders, M. P., de Visser, K. E., Schiller, J. T., M�ller, M., & Kast, W. M. (1999) · Journal of Cellular Biochemistry · Cited by 53
Kuroki, H., Morisaki, T., Matsumoto, K., Onishi, H., Baba, E., Tanaka, M., & Katano, M. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0394-7 · Cited by 53
Mena, I., Vivó, A., Pérez, E., & Portela, A. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5016-5024.1996 · Cited by 53
Dillon, S. B., Demuth, S. G., Schneider, M., Weston, C. B., Jones, C. S., Young, J. F., Scott, M. O., Bhatnaghar, P. K., LoCastro, S. M., & Hanna, N. (1992) · Vaccine · doi:10.1016/0264-410x(92)90369-u · Cited by 52
Moerdyk-Schauwecker, M. J., Hwang, S., & Grdzelishvili, V. Z. (2009) · Virology Journal · doi:10.1186/1743-422x-6-166 · Cited by 52
Biomedical Nanotechnology Using Virus-Based Nanoparticles
Destito, G., Schneemann, A., & Manchester, M. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-69379-6_5 · Cited by 51
Rovinski, B., Haynes, J. R., Cao, S. X., James, O., Sia, C., Zolla‐Pazner, S., Matthews, T. J., & Klein, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4003-4012.1992 · Cited by 51
Lévy-Bruhl, D., Bousquet, V., King, L. A., O’Flanagan, D., Bacci, S., Lopalco, P. L., & Salmaso, S. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.023 · Cited by 51
Morikawa, S., Booth, T. F., & Bishop, D. H. L. (1991) · Virology · doi:10.1016/0042-6822(91)90141-w · Cited by 50
The synthesis of blocked triplet-phosphoramidites and their use in mutagenesis
Ono, A. M., Matsuda, A., Zhao, J., & Santi, D. V. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.22.4677 · Cited by 50
Kao, C. C., Ni, P., Hema, M., Huang, X., & Dragnea, B. G. (2010) · Molecular Plant Pathology · doi:10.1111/j.1364-3703.2010.00678.x · Cited by 50
Zhang, L., Parham, N. J., Zhang, F., Aasa-Chapman, M. M. I., Gould, E. A., & Zhang, H. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.061 · Cited by 49
Ameiss, K. A., Ashraf, S., Kong, W., Pekosz, A. S., Wu, W.-H., Milich, D. R., Billaud, J.-N., & Curtiss, R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.083 · Cited by 49
Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen
Hayden, C. A., Streatfield, S. J., Lamphear, B. J., Fake, G. M., Keener, T. K., Walker, J. H., Clements, J. D., Turner, D. D., Tizard, I. R., & Howard, J. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.072 · Cited by 49
Tumor immunity against adult T‐cell leukemia
Kannagi, M., Harashima, N., Kurihara, K., Ohashi, T., Utsunomiya, A., Tanosaki, R., Masuda, M., Tomonaga, M., & Okamura, J. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00050.x · Cited by 49
Liu, W., Jiang, H., Zhou, J., Yang, X., Tang, Y., Fang, D., & Jiang, L. (2009) · Virus Genes · doi:10.1007/s11262-009-0418-2 · Cited by 49
Human papillomavirus vaccines in plants
Giorgi, C., Franconi, R., & Rybicki, E. P. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.84 · Cited by 49
Weinstein, T., Chagnac, A., Boaz, M., Ori, Y., Herman, M., Zevin, D., Schmilovitz‐Weiss, H., & Gafter, U. (2004) · Nephron Clinical Practice · doi:10.1159/000078403 · Cited by 49
Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles
Sedlik, C., Sarraseca, J., Rueda, P., Leclerc, C., & Casal, J. I. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-9-2361 · Cited by 48
Peters, B. S., CHEINGSONG-POPOV, R., Callow, D., Foxall, R. B., Patou, G., Hodgkin, K., & Weber, J. N. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)92814-0 · Cited by 47
Chen, T., Chen, T.-H., Hu, C., Liao, J.-T., Lee, C., Liao, J., Lin, M.-Y., Liu, H., Wang, M.-Y., Lin, N., et al. (2012) · Virus Research · doi:10.1016/j.virusres.2012.02.021 · Cited by 47
Grigsby, I. F., Zhang, W., Johnson, J. L., Fogarty, K., Chen, Y., Rawson, J. M. O., Crosby, A. J., Mueller, J. D., & Mansky, L. M. (2010) · Retrovirology · doi:10.1186/1742-4690-7-75 · Cited by 47
Kazāks, A., Balmaks, R., Voronkova, T., Ose, V., & Pumpens, P. (2008) · Biotechnology Journal · doi:10.1002/biot.200800160 · Cited by 47
Self-citationTransforming Activity of Bovine and Human Papillomaviruses in Cultured Cells
DiMaio, D. (1991) · Advances in cancer research · doi:10.1016/s0065-230x(08)60480-7 · Cited by 46
Lear, J. D. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00778-6 · Cited by 46
Chimeric calicivirus-like particles elicit specific immune responses in pigs
Crisci, E., Fraile, L. J., Moreno, N., Blanco, E., Cabezón, R., Costa, C., Mussá, T., Baratelli, M., Martínez-Orellana, P., Ganges, L., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.069 · Cited by 46
Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma
Cantarella, G., Liniger, M., Zúñiga, A., Schiller, J. T., Billeter, M., Naim, H. Y., & Glueck, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.061 · Cited by 46
Mueller, A., Kadri, A., Jeske, H., & Wege, C. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.02.026 · Cited by 46
Assembly of HIV GAG-B-Galactosidase Fusion Proteins into Virus Particles
Wang, C.-T., Stegeman-Olsen, J., Zhang, Y., & Barklis, E. (1994) · Virology · doi:10.1006/viro.1994.1215 · Cited by 45
Mosaic Qβ coats as a new presentation model
Vasiljeva, I., Kozlovska, T., Cielēns, I., Zajakina, A., Kazāks, A., Ose, V., & Pumpens, P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00716-9 · Cited by 45
Self-citationUtilization of a Protein “Shuttle” To Load Vault Nanocapsules with Gold Probes and Proteins
Goldsmith, L. E., Pupols, M., Kickhoefer, V. A., Rome, L. H., & Monbouquette, H. G. (2009) · ACS Nano · doi:10.1021/nn900555d · Cited by 45
Rossen, J. W. A., de Beer, R., Godeke, G.-J., Raamsman, M. J. B., Horzinek, M. C., Vennema, H., & Rottier, P. J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.497-503.1998 · Cited by 45
Bach, P., Kamphuis, E., Odermatt, B., Sutter, G., Buchholz, C. J., & Kalinke, U. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5839 · Cited by 44
Bluetongue virus evolution: Sequence analyses of the genomic S1 segments and major core protein VP7
Kowalik, T. F., & Li, J. K.-K. (1991) · Virology · doi:10.1016/0042-6822(91)90911-t · Cited by 44
Terajima, M., Cruz, J., Leporati, A. M., Orphin, L., Babon, J. A. B., Co, M. D. T., Pazoles, P., Jameson, J., & Ennis, F. A. (2008) · Journal of Virology · doi:10.1128/jvi.01047-08 · Cited by 44
Lin, Y., Borenstein, L. A., Selvakumar, R., Ahmed, R., & Wettstein, F. O. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.382-389.1993 · Cited by 43
Design of therapeutic vaccines: hepatitis B as an example
Kutscher, S., Bauer, T., Dembek, C. J., Sprinzl, M. F., & Protzer, U. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00303.x · Cited by 43
Sharma, P. K., & Ikegami, M. (2009) · Virus Research · doi:10.1016/j.virusres.2009.04.019 · Cited by 43
Targeted Therapy for Kaposi Sarcoma
Sullivan, R. J., Pantanowitz, L., & Dezube, B. J. (2009) · BioDrugs · doi:10.2165/00063030-200923020-00001 · Cited by 43
Engineering parvovirus-like particles for the induction of B-cell, CD4+ and CTL responses
Rueda, P., Martinez-Torrecuadrada, J. L., Sarraseca, J., Sedlik, C., del Barrio, M., Hurtado, A. M., Leclerc, C., & Casal, J. I. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00202-9 · Cited by 43
Ju, H., Wei, N., Wang, Q., Wang, C., Jing, Z., Guo, L., Liu, D., Gao, M., Ma, B., & Wang, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.129 · Cited by 42
Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response
Peacey, M., Wilson, S., Perret, R., Ronchese, F., Ward, V. K., Young, V. L., Young, S. L., & Baird, M. A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.074 · Cited by 42
Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli
Lee, C., Yan, Y.-P., Liang, S., & Wang, T. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-69 · Cited by 42
Okinaka, Y., Mise, K., Suzuki, E., Okuno, T., & Furusawa, I. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5385-5390.2001 · Cited by 42
Chimeric Parvovirus B19 Capsids for the Presentation of Foreign Epitopes
Brown, C. S., Welling‐Wester, S., Feijlbrief, M., van Lent, J. W. M., & Spaan, W. J. M. (1994) · Virology · doi:10.1006/viro.1994.1059 · Cited by 41
Characterization of polymorphism displayed by the coat protein mutants of tomato bushy stunt virus
Hsu, C., Singh, P. N. P., Ochoa, W. F., et al. (2006) · Virology · doi:10.1016/j.virol.2006.02.038 · Cited by 39
Pumpens, P., Ražanskas, R., Pushko, P., Renhof, R., Gusars, I., Skrastiņa, D., Ose, V., Borisova, G., Sominskaya, I., Petrovskis, I., et al. (2002) · Intervirology · doi:10.1159/000050084 · Cited by 39
Self-citationAdhikary, D., Behrends, U., Feederle, R., Delecluse, H., & Mautner, J. (2008) · Journal of Virology · doi:10.1128/jvi.02227-07 · Cited by 39
BPV1 E2 Protein Enhances Packaging of Full-Length Plasmid DNA in BPV1 Pseudovirions
Zhao, K., Hengst, K., Liu, W., Liu, Y. H., Liu, X. S., McMillan, N. A. J., & Frazer, I. H. (2000) · Virology · doi:10.1006/viro.2000.0348 · Cited by 38
Functional Analysis of RNA Binding by the Hepatitis C Virus RNA-dependent RNA Polymerase
Kim, Y. C., Russell, W. K., Ranjith-Kumar, C. T., Thomson, M., Russell, D. H., & Kao, C. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508145200 · Cited by 38
Kueng, H. J., Reichl, V., Haiderer, D., Raposo, G., Théry, C., Derdak, S. V., Schmetterer, K. G., Neunkirchner, A., Sillaber, C., Seed, B., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00682-07 · Cited by 38
A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae
Sun, S., Li, W., Sun, Y., Pan, Y., & Li, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.122 · Cited by 38
Eriksson, M., Andreasson, K., Weidmann, J., Lundberg, K., Tegerstedt, K., Dalianis, T., & Ramqvist, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023828 · Cited by 38
Bourmakina, S. V., & García‐Sastre, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7926-7932.2005 · Cited by 38
Cell-Penetrating Peptides Derived from Viral Capsid Proteins
Qi, X., Droste, T., & Kao, C. C. (2010) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-07-10-0147 · Cited by 37
Tobin, G. J., Nagashima, K., & Gonda, M. A. (1996) · Methods · doi:10.1006/meth.1996.0096 · Cited by 36
Yoshiyama, H., Mo, H., Moore, J. P., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.974-978.1994 · Cited by 36
A T = 1 capsid formed by protein of brome mosaic virus in the presence of trypsin
Cuillel, M., Jacrot, B., & Zulauf, M. (1981) · Virology · doi:10.1016/0042-6822(81)90008-8 · Cited by 35
Peptidase E, a Peptidase Specific for N-Terminal Aspartic Dipeptides, Is a Serine Hydrolase
Lassy, R. A. L., & Miller, C. G. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.9.2536-2543.2000 · Cited by 34
Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
Jeoung, H.-Y., Lee, W., Jeong, W., Shin, B., Choi, H., Lee, H. S., & An, D.-J. (2011) · Virology Journal · doi:10.1186/1743-422x-8-170 · Cited by 34
Mehrotra, S., Stevens, R., Zengou, R., Chakraborty, N. G., Butterfield, L. H., Economou, J. S., Dorsky, D. I., & Mukherji, B. (2003) · PubMed · Cited by 33
Röhn, T. A., Ralvenius, W. T., Paul, J., Borter, P., Hernandez, M., Witschi, R., Grest, P., Zeilhofer, H. U., Bachmann, M. F., & Jennings, G. T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000030 · Cited by 33
Innate signaling regulates cross‐priming at the level of DC licensing and not antigen presentation
Keller, S. A., Schwarz, K., Manolova, V., von Allmen, C. E., Kinzler, M. G., Bauer, M., Muntwiler, S., Saudan, P., & Bachmann, M. F. (2009) · European Journal of Immunology · doi:10.1002/eji.200939559 · Cited by 33
Villegas-Méndez, A., Garin, M. I., Pineda‐Molina, E., Veratti, E., Bueren, J. A., Fender, P., & Lenormand, J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.16 · Cited by 33
Xu, Y., & Ganem, D. (2006) · Journal of General Virology · doi:10.1099/vir.0.82375-0 · Cited by 33
Targeting of viral glycoproteins to the Golgi complex
Hobman, T. C. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90126-c · Cited by 33
Lu, X., Thompson, J. R., & Perry, K. L. (2012) · Journal of General Virology · doi:10.1099/vir.0.040170-0 · Cited by 33
Broomall, E. M., Reynolds, S. M., & Jacobson, R. M. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.03.2129 · Cited by 32
Lee, S.-K., & Hacker, D. L. (2001) · Virology · doi:10.1006/viro.2001.0979 · Cited by 32
Okamoto, S., Yoshii, H., Matsuura, M., Kojima, A., Ishikawa, T., Akagi, T., Akashi, M., Takahashi, M., Yamanishi, K., & Mori, Y. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05412-11 · Cited by 32
‘Genome gating’; polarized intranuclear trafficking of influenza virus RNPs
Elton, D. M., Amorim, M. J., Medcalf, L., & Digard, P. (2005) · Biology Letters · doi:10.1098/rsbl.2004.0253 · Cited by 32
Hovden, A., Karlsen, M., Jonsson, R., Aarstad, H. J., & Appel, S. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-2 · Cited by 32
Maynard, J. E. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112520 · Cited by 32
Epstein-Barr virus vaccine development: a lytic and latent protein cocktail
Timothy, D. L. (2008) · Frontiers in bioscience · doi:10.2741/3126 · Cited by 31
Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice
Zou, Y., Sonderegger, I., Lipowsky, G., Jennings, G. T., Schmitz, N., Landi, M., Köpf, M., & Bachmann, M. F. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.048 · Cited by 30
Sivakumaran, K., Choi, S., Hema, M., & Kao, C. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6091-6101.2004 · Cited by 30
Challenges in creating a vaccine to prevent hepatitis E
Maloney, B. J., Takeda, N., Suzaki, Y., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.11.020 · Cited by 30
Nuzzaci, M., Vitti, A., Condelli, V., Lanorte, M. T., Tortorella, C., Boscia, D., Piazzolla, P., & Piazzolla, G. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.01.021 · Cited by 30
Plevka, P., Kazāks, A., Voronkova, T., Koteloviča, S., Dišlers, A., Liljas, L., & Tārs, K. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.047 · Cited by 30
Luque, D., González, J. M., Gómez-Blanco, J., Marabini, R., Chichón, F. J., Mena, I., Angulo, I., Carrascosa, J. L., Verdaguer, N., Trus, B. L., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07050-11 · Cited by 30
Jia, Q., Freeman, M. L., Yager, E. J., McHardy, I. H., Tong, L. M., Martinez-Guzman, D., Rickabaugh, T. M., Hwang, S., Blackman, M. A., Sun, R., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01543-09 · Cited by 30
Specific Immobilization of Firefly Luciferase through a Biotin Carboxyl Carrier Protein Domain
Wang, C.-Y., Hitz, S. L., Andrade, J. D., et al. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2006 · Cited by 29
Chen, Y., Aspelund, A., Kemble, G. W., & Jin, H. (2008) · Virology · doi:10.1016/j.virol.2008.08.010 · Cited by 28
Tagliamonte, M., Visciano, M. L., Tornesello, M. L., Stradis, A. D., Buonaguro, L., & Buonaguro, L. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.004 · Cited by 28
Thermal nanostructure: An order parameter multiscale ensemble approach
Cheluvaraja, S., & Ortoleva, P. (2010) · The Journal of Chemical Physics · doi:10.1063/1.3316793 · Cited by 28
Human JC virus-like particles as a gene delivery vector
Chang, C.-F., Wang, M., Ou, W., Chen, P., Shen, C., Lin, P. Y., Fang, C., & Chang, D. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.583914 · Cited by 28
Reichl, V., Jahn‐Schmid, B., Kueng, H. J., Schmetterer, K. G., Haiderer, D., Neunkirchner, A., Fischer, G., Hartl, A. J., Thalhamer, J., Steinberger, P., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.04.008 · Cited by 28
Andreasson, K., Tegerstedt, K., Eriksson, M., Curcio, C., Cavallo, F., Forni, G., Dalianis, T., & Ramqvist, T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23920 · Cited by 28
Westmoreland, S. V., & Mansfield, K. G. (2008) · PubMed · Cited by 27
T-cell immunotherapy of cancer
Melief, C. J. M., & Kast, W. M. (1991) · Research in Immunology · doi:10.1016/0923-2494(91)90042-h · Cited by 27
A Malaria Vaccine Candidate Based on a Hepatitis B Virus Core Platform
Sällberg, M., Hughes, J. L., Jones, J. E., Phillips, T. R., & Milich, D. R. (2002) · Intervirology · doi:10.1159/000067928 · Cited by 27
Choudhury, S., Kakkar, V., Suman, P., Chakrabarti, K., Vrati, S., & Sk, G. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.002 · Cited by 27
Michel, M., Lone, Y. C., Centlivre, M., Roux, P., Wain–Hobson, S., & Sala, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.08.014 · Cited by 27
Guan, Q., Ma, Y., Hillman, C.-L., Ma, A., Zhou, G., Qing, G., & Peng, Z. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.058 · Cited by 26
From assembly to virus particle budding: Pertinence of the detergent resistant membranes
Grenet, A.-S. G., Mottet-Osman, G., & Roux, L. (2005) · Virology · doi:10.1016/j.virol.2005.09.035 · Cited by 25
Murata, Y., Lightfoote, P. M., Rose, R. C., & Walsh, E. E. (2009) · Virology Journal · doi:10.1186/1743-422x-6-81 · Cited by 25
Computational studies of proton transport through the M2 channel
Wu, Y., & Voth, G. A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00779-8 · Cited by 25
Sistigu, A., Bracci, L., Valentini, M., Proietti, E., Bona, R., Negri, D. R. M., Ciccaglione, A. R., Tritarelli, E., Nisini, R., Equestre, M., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.059 · Cited by 24
Mattiacio, J. L., Walter, S., Brewer, M., Domm, W., Friedman, A. E., & Dewhurst, S. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.038 · Cited by 24
Misumi, S., Nakajima, R., Takamune, N., & Shoji, S. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11614-11620.2001 · Cited by 24
Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer's disease
Vitti, A., Piazzolla, G., Condelli, V., Nuzzaci, M., Lanorte, M. T., Boscia, D., Stradis, A. D., Antonaci, S., Piazzolla, P., & Tortorella, C. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.07.039 · Cited by 24
Kali, J., & Yang, Y. (1990) · Virology · doi:10.1016/0042-6822(90)90353-s · Cited by 23
Advances in HTLV-1 Peptide Vaccines and Therapeutics
Lynch, M., & Kaumaya, P. T. P. (2006) · Current Protein and Peptide Science · doi:10.2174/138920306776359803 · Cited by 23
Miller, M. A., Murphey‐Corb, M., & Montelaro, R. C. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.1153 · Cited by 23
Sundaram, R., Lynch, M. P., Rawale, S. V., Dakappagari, N. K., Young, D. C., Walker, C. M., Lemonnier, F. A., Jacobson, S., & Kaumaya, P. T. P. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200411010-00001 · Cited by 20
Asymmetric Contributions to RNA Binding by the Thr45Residues of the MS2 Coat Protein Dimer
Peabody, D. S., & Chakerian, A. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25403 · Cited by 20
Voronkova, T., Grosch, A., Kazāks, A., Ose, V., Skrastiņa, D., Sasnauskas, K., Jandrig, B., Arnold, W., Scherneck, S., Pumpens, P., et al. (2002) · Viral Immunology · doi:10.1089/088282402320914557 · Cited by 19
Self-citationYin, Y., Li, H., Wu, S., Dong, D., Zhang, J., Fu, L. L., Xu, J., & Chen, W. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.012 · Cited by 19
Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope
Huang, M., Essex, M., & Lee, T. H. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.5073-5079.1991 · Cited by 18
Gale, A. J., Elias, D. J., Averell, P. M., Teirstein, P. S., Buck, M., Brown, S. D., Polonskaya, Z., Udit, A. K., & Finn, M. G. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.03.021 · Cited by 17
Rubella Virus Capsid Protein: A Small Protein with Big Functions
Ilkow, C. S., Willows, S. D., & Hobman, T. C. (2010) · Future Microbiology · doi:10.2217/fmb.10.27 · Cited by 15
Cao, Y., Sun, P., Fu, Y., Bai, X., Tian, F., Liu, X., Lu, Z., & Liu, Z. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0295-8 · Cited by 15
Delecluse, H., Feederle, R., Behrends, U., & Mautner, J. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.09.001 · Cited by 14
Tsuji, Y., Deo, V. K., Kato, T., & Park, E. Y. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.07.008 · Cited by 14
In Vitro encapsidation of the four RNA species of brome mosaic virus
Herzog, M., & Hirth, L. (1978) · Virology · doi:10.1016/0042-6822(78)90006-5 · Cited by 14
[34] Use of fusions to viral coat proteins as antigenic carriers for vaccine development
Stockley, P. G., & Mastico, R. A. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)26076-x · Cited by 12
Tumor Targeting Using Canine Parvovirus Nanoparticles
Singh, P. N. P. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-69379-6_6 · Cited by 11
Hummel, K. B., Martin, M. L., & Auperin, D. D. (1992) · Virus Research · doi:10.1016/0168-1702(92)90101-e · Cited by 11
Nishida, Y., Shibata, K., Yamasaki, M., Sato, Y., & Abé, M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.051 · Cited by 11
Gissmann, L., Jochmus, I., Nindl, I., & MÜLLER, M. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb43998.x · Cited by 10
Petraitytė-Burneikienė, R., Nalivaiko, K., Lasickienė, R., Firantienė, R., Ėmužytė, R., Sasnauskas, K., & Žvirblienė, A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.07.009 · Cited by 8
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jeevanandam, J., Barhoum, A., Chan, Y. S., Dufresne, A., & Danquah, M. K. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.98 · Cited by 3,297
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
A DNA transfection system for generation of influenza A virus from eight plasmids
Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., & Webster, R. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100133697 · Cited by 1,565
Metadata
- Authors
- Pushko, P., Pumpens, P., & Grens, E.
- Venue
- Intervirology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 56
- Issue
- 3
- Pages
- 141-165
- ISSN
- 0300-5526 (ISSN-L)
- 1423-0100
- OpenAlex
- W2046182783
- Cited by
- 5,950
- References
- 770
- FWCI
- 295.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.